Portfolio (Quarterly)
Guide ↗
Persistent Asset Partners Ltd
· CIK 0002056052| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 301 | — CALL | SELLAS LIFE SCIENCES GROUP I | — | 1,145.0 | $37K | 0.02% | +225.0 | +24.5% | $32.50 | — |
| 302 | — | CLIMB BIO INC | — | 9,228.0 | $37K | 0.02% | -19K | -67.3% | $4.00 | — |
| 303 | — PUT | SPDR SERIES TRUST | — | 669.0 | $36K | 0.02% | NEW | — | $54.18 | — |
| 304 | — CALL | EVOLUS INC | — | 318.0 | $33K | 0.01% | NEW | — | $102.50 | — |
| 305 | XBIT | XBIOTECH INC | Healthcare | 13,565.0 | $32K | 0.01% | NEW | — | $2.39 | +2.9% |
| 306 | — CALL | MOONLAKE IMMUNOTHERAPEUTICS | — | 126.0 | $30K | 0.01% | +65.0 | +106.6% | $240.41 | — |
| 307 | PRTC | PURETECH HEALTH PLC | Healthcare | 1,759.0 | $29K | 0.01% | +74.0 | +4.4% | $16.70 | +7.5% |
| 308 | — | INHIBRX BIOSCIENCES INC | — | 346.0 | $27K | 0.01% | NEW | — | $79.00 | — |
| 309 | — CALL | JANUX THERAPEUTICS INC | — | 80.0 | $26K | 0.01% | NEW | — | $324.96 | — |
| 310 | — PUT | ROIVANT SCIENCES LTD | — | 860.0 | $26K | 0.01% | +169.0 | +24.5% | $30.03 | — |
| 311 | — PUT | TG THERAPEUTICS INC | — | 265.0 | $24K | 0.01% | NEW | — | $91.32 | — |
| 312 | — CALL | VIR BIOTECHNOLOGY INC | — | 238.0 | $21K | 0.01% | NEW | — | $87.99 | — |
| 313 | — CALL | INSMED INC | — | 142.0 | $20K | 0.01% | NEW | — | $143.21 | — |
| 314 | — CALL | BIOAGE LABS INC | — | 61.0 | $20K | 0.01% | NEW | — | $333.03 | — |
| 315 | MELI | MERCADOLIBRE INC | Consumer Cyclical | 10.0 | $20K | 0.01% | NEW | — | $2014.30 | -20.2% |
| 316 | — | VISTAGEN THERAPEUTICS INC | — | 26,612.0 | $18K | 0.01% | -49K | -64.7% | $0.66 | — |
| 317 | — | EDESA BIOTECH INC | — | 12,319.0 | $17K | 0.01% | NEW | — | $1.42 | — |
| 318 | — PUT | LYELL IMMUNOPHARMA INC | — | 10.0 | $16K | 0.01% | NEW | — | $1629.50 | — |
| 319 | — PUT | PRAXIS PRECISION MEDICINES I | — | 230.0 | $16K | 0.01% | — | — | $67.83 | — |
| 320 | — CALL | CENTESSA PHARMACEUTICALS PLC | — | 57.0 | $15K | 0.01% | NEW | — | $271.54 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
56.7%
Technology
14.5%
Financial Services
14.2%
Consumer Cyclical
3.6%
Communication Services
3.5%
Energy
3.5%
Basic Materials
3.0%
Consumer Defensive
0.6%
Industrials
0.4%